Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Ed Field discovered his passion for building biotechnology innovation while working with an equity-backed biopharma start-up ...

The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

If you’re looking for an OTC medication that’ll ease pain and quell inflammation, there are several great options to choose ...

Fir Park midfielder returned to top team action after a year out this week - and is now looking forward to making up for lost ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Still, many analysts on Wall Street think the correction is way overdone. Regeneron's stock could soar by 50% in the next ...

Osteoarthritis disproportionally affects postmenopausal women, and a biological mechanism for why this occurs has been ...

Rates of myalgic encephalomyelitis/chronic fatigue syndrome have dramatically increased since pre-pandemic times. A new large ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.